Microplastics in the Human Body: The Hidden Health Risk You’re Not Being Tested For
On April 2nd, two major U.S. agencies made a coordinated announcement that received far less attention than it deserved.
The Environmental Protection Agency (EPA) formally identified microplastics as a priority contaminant in U.S. drinking water. At the same time, the Department of Health and Human Services (HHS) launched a $144 million research initiative—STOMP—focused on measuring and removing microplastics from the human body.
This was not a minor update. It was a signal.
For years, microplastics have been discussed as an environmental issue. Now, they are being recognized as a human health issue.
And the most concerning part is this: we are only beginning to understand how much of this material is accumulating inside us.
The Reality: Microplastics Are Already Inside the Human Body
Microplastics are small plastic particles, typically defined as less than 5 millimeters in size. Many are far smaller—down to microscopic and even nanoscopic levels.
These particles originate from:
- Plastic packaging and food containers
- Water bottles
- Synthetic clothing fibers
- Personal care products
- Environmental degradation of larger plastics
Once released, they enter the air, food supply, and water systems.
Human exposure occurs through:
- Ingestion (food and water)
- Inhalation (airborne particles)
- Dermal contact (to a lesser extent)
Recent studies have confirmed that microplastics are not just passing through the body. They are accumulating.
They have been detected in:
- Blood
- Lung tissue
- Liver
- Placenta
- And most recently—brain tissue
A Rapid Increase in Brain Accumulation
A recent study from the University of New Mexico found that microplastic concentrations in human brain tissue have increased by approximately 50% over the past 8 years.
This finding raises important questions:
- How are these particles crossing the blood-brain barrier?
- What are the long-term neurological implications?
- Why is this increasing so rapidly?
While definitive answers are still emerging, the trend is clear: exposure is increasing, and accumulation is measurable.
Why This Problem Is So Easy to Miss
Most people assume that if something is wrong internally, it will show up on routine lab work.
This is not the case with microplastics.
Standard blood testing evaluates:
- Cholesterol
- Blood sugar
- Thyroid function
- Inflammatory markers
What it does not evaluate:
- Microplastic particle count
- Particle size distribution
- Plastic type or composition
This creates a blind spot.
You can have measurable accumulation and feel completely normal.
Or, more concerning, you may have subtle symptoms that are attributed to other causes because this variable is not being considered.
The Silent Nature of Microplastic Accumulation
Unlike acute toxins, microplastics do not typically produce immediate symptoms.
Instead, they may contribute to:
- Chronic low-grade inflammation
- Oxidative stress
- Endocrine disruption
- Immune system dysregulation
These processes are gradual.
They often overlap with other conditions, making them difficult to isolate without targeted evaluation.
This is what makes microplastics particularly challenging—they are not obvious.
What We Currently Understand About Health Impact
Research is still evolving, but early data suggests several potential mechanisms:
1. Inflammatory Response
Microplastics may trigger immune activation, leading to chronic inflammation.
2. Oxidative Stress
Particles can generate reactive oxygen species, damaging cellular structures.
3. Hormonal Disruption
Many plastics contain endocrine-disrupting compounds such as BPA and phthalates.
4. Cellular Interference
Particles may interfere with normal cellular signaling and transport mechanisms.
While these mechanisms are still being studied, they align with broader patterns seen in chronic disease.
The Gap Between Awareness and Measurement
Public awareness of microplastics has increased significantly.
However, awareness without measurement creates uncertainty.
You may know the problem exists, but not whether it applies to you personally.
This is where clinical evaluation becomes important.
Why Measurement Matters
In medicine, effective treatment begins with data.
Without measurement:
- You cannot establish a baseline
- You cannot assess severity
- You cannot track improvement
This is particularly important for exposures that do not produce immediate symptoms.
Microplastics fall into this category.
A More Advanced Approach to Evaluation
Emerging diagnostic approaches now allow for the assessment of:
- Microplastic particle count
- Size distribution
- Concentration levels
- Material composition
These tools are not yet part of routine care.
However, they represent a shift toward more comprehensive environmental health assessment.
Rather than relying on assumptions, clinicians can begin to quantify exposure.
Why This Type of Testing Is Different
Traditional testing evaluates downstream effects:
- Inflammation
- Hormone imbalance
- Metabolic disruption
Microplastic testing evaluates the upstream factor—the exposure itself.
This distinction matters because:
- It identifies a potential root contributor
- It allows for targeted intervention
- It provides measurable feedback over time
In other words, it shifts the focus from symptoms to cause.
Why This Matters Now
The recent EPA and HHS announcements indicate that microplastics are no longer considered a theoretical concern.
They are now a recognized priority in environmental and human health research.
This suggests that:
- Exposure is widespread
- Accumulation is measurable
- Health implications are significant enough to warrant large-scale investigation
Waiting for symptoms to appear may not be the most effective strategy.
What an Integrative Approach Looks Like
An integrative approach to environmental exposure typically includes:
1. Identification
Understanding potential sources of exposure.
2. Measurement
Assessing internal burden where possible.
3. Support
Optimizing the body’s natural detoxification pathways.
4. Reassessment
Evaluating whether interventions are effective.
This framework is not new—it is used in heavy metal toxicity, mold exposure, and other environmental health conditions.
It is now being applied to microplastics.
Reducing Exposure: Practical Considerations
While complete avoidance is unrealistic, exposure can be reduced:
- Avoid heating food in plastic containers
- Use glass or stainless steel for food storage
- Filter drinking water when possible
- Limit use of single-use plastics
- Choose natural fiber clothing
These steps do not eliminate exposure but may reduce overall burden.
The Bigger Picture: Environmental Health Is Personal Health
Microplastics represent a broader shift in how we think about health.
Environmental exposures are no longer separate from medicine—they are part of it.
Understanding this connection allows for a more complete view of chronic illness.
When Should You Consider Further Evaluation?
You may consider more advanced assessment if you:
- Have unexplained chronic symptoms
- Are exposed to high levels of plastics (occupational or lifestyle)
- Want a more comprehensive understanding of your health
- Are already addressing other environmental factors
Not every patient requires this level of evaluation.
However, for some, it may provide valuable insight.
Summary
Microplastics are no longer just an environmental concern. They are a measurable presence in the human body.
Standard testing does not evaluate this variable, creating a gap in our understanding of health.
Emerging diagnostic tools are beginning to fill that gap, offering a more complete picture of exposure and its potential impact.
As research evolves, the ability to measure and respond to these exposures will likely become an increasingly important part of preventive and functional medicine.
The key takeaway is simple: what is not measured is often overlooked.
And in the case of microplastics, that oversight may be more significant than we once believed.
Scientific References
- Leslie HA, et al. Discovery and quantification of plastic particle pollution in human blood. Environment International.
- Ragusa A, et al. Plasticenta: First evidence of microplastics in human placenta. Environment International.
- University of New Mexico Study on Microplastics in Brain Tissue.
- WHO Report on Microplastics in Drinking Water.
- EPA and HHS STOMP Initiative Announcements.